Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer
about
Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer.Retrospective Proteomic Screening of 100 Breast Cancer Tissues.Non-metabolic functions of glycolytic enzymes in tumorigenesis.Screening of biomarkers for prediction of response to and prognosis after chemotherapy for breast cancers.Cofilin-1 and phosphoglycerate kinase 1 as promising indicators for glioma radiosensibility and prognosis.PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process.PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer.PGK1 and GRP78 overexpression correlates with clinical significance and poor prognosis in Chinese endometrial cancer patients.Characteristics of testis-specific phosphoglycerate kinase 2 and its association with human sperm quality.miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming.Proteomic analysis of rat serum revealed the effects of chronic sleep deprivation on metabolic, cardiovascular and nervous systemIsobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells
P2860
Q37226057-42D60676-31E3-4E78-B9C3-C9D45318823AQ38689543-A86E27D1-D8ED-477B-8483-87570404BE0DQ38994977-89D40D29-DBE2-4906-9543-1C8D37FDCDEFQ39741084-A209776B-F2C5-42BE-95F4-E17B69BD84B2Q41549645-DDF3C35F-33FE-4BC7-A19A-A35D553F919DQ41573077-13D96DD4-0C02-4879-B5E3-201362C841E1Q47096405-8E70B6D6-A148-4256-BBAC-D258354D545CQ49165472-5F9DC042-DF08-4FC0-8045-A7F664742F95Q50044031-71AA3E01-F79E-4281-B45E-D471515C8CDAQ50064930-5801FCEB-40FF-41D3-94C9-ED4B84065075Q58713801-FD376360-F607-426C-886F-0CC8AA23A9E5Q58764017-AC735552-8DBE-40A1-9A9A-12810E2958B4
P2860
Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phosphoglycerate kinase-1 is a ...... xel treatment in breast cancer
@ast
Phosphoglycerate kinase-1 is a ...... xel treatment in breast cancer
@en
type
label
Phosphoglycerate kinase-1 is a ...... xel treatment in breast cancer
@ast
Phosphoglycerate kinase-1 is a ...... xel treatment in breast cancer
@en
prefLabel
Phosphoglycerate kinase-1 is a ...... xel treatment in breast cancer
@ast
Phosphoglycerate kinase-1 is a ...... xel treatment in breast cancer
@en
P2093
P2860
P356
P1476
Phosphoglycerate kinase-1 is a ...... xel treatment in breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2015.114
P407
P577
2015-03-31T00:00:00Z